The global dental anesthesia market size was valued at USD 1.88 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030. Anesthetics are drugs that can induce reversible sensation loss. They are typically given to help with the surgery. The two vasoconstrictors used in the US are epinephrine and levonordefrin. Dental anesthetics that contain epinephrine include prilocaine, bupivacaine, lidocaine, and articaine. Before performing any dental surgery, dental anesthetics are administered to the inner cheek or gum.
The rising cases of dental problems are likely to drive the dental anesthesia market. The market for dental anesthetics will expand dramatically over the next years as a result of rising disposable incomes and rising oral awareness. Dental anesthetic is anticipated to increase in popularity in growing nations like China, India, and Brazil over the next few years because of their rising income levels and relatively high DMFT indices (decayed, missing, and filled teeth index).
Global demand for dental anesthetics is predicted to rise as a result of the rising incidence rate of cancer, periodontitis, and gingivitis. Additionally, it is projected that cigarette and tobacco usage will increase, and dietary habits will change, leading to an increase in maxillofacial and oral dental problems. The market for dental anesthesia is anticipated to develop as a result of the increasing frequency of dental caries and tooth decay around the world, rising public awareness of the value of oral health, and government efforts to improve access to dental care.
COVID-19 has affected all the markets including the dental industry as there was a complete lockdown imposed by the government as a precautionary measure. The supply chain for dental anesthesia was also affected. The pandemic has caused a huge disruption in the supply chain of the overall medical device industry. Due to international constraints, there was a reduction in dental procedures in 2020 and 2021, which had a negative effect on the market due to the coronavirus outbreak. The demand for dental anesthetics is anticipated to rise during the projected period due to rising dental care awareness and shifting demographics.
Based on the type segment, the dental anesthesia market is segmented into local, general, and sedation. Local dental anesthesia is expected to dominate the dental anesthesia market in terms of revenue with a market share of 52.8% in 2022. The most popular kind of anesthesia is a local anesthetic. Simpler treatments, such as filling a cavity, that take less time to complete and are typically less difficult, are treated with a local anesthetic.
In most situations, it is the safest choice and also has few negative effects, hence is preferred the most. Since the eighteenth century, clinical dentists have employed local anesthetics to reduce or eliminate the discomfort associated with invasive procedures. Additionally, oral and maxillofacial surgery commonly makes use of local anesthetics. Dental professionals most frequently utilize local anesthetics (LAs). They are safer medications. More than 40% of dental emergencies result in discomfort that requires an injection of LA.
Based on end use, the dental anesthesia market is segmented into dental hospitals, dental clinics, and others. The dental clinic end-use segment accounted for the largest share 53.7% in 2021. The growing number of dental offices worldwide and the widespread usage of advanced dentistry by both large and small dental practices are the primary drivers fuelling the growth of the dental clinics segment. It is also projected that the increasing number of dental clinics, especially in developed countries, will accelerate the expansion of the market. Depending on the area, public healthcare provides dentists in industrialized nations with adequate compensation for their treatments and services.
Given the rising popularity of the dental franchise model, there may also be an opportunity for dental clinics to flourish. A dental franchise model offers advantages including increased negotiating power and cost savings through economies of scale. For example, the Indian dental practice chain Clove Dental spent INR 171 crore ($25 million) in September 2018 to grow its franchise network to 600 clinics in India over the following five years. This franchise model aids in lowering treatment and service costs overall, which will increase the number of patients using dental services and propel the market for dental clinics.
Asia Pacific dominated the dental anesthesia market capturing a 38.6% market share in 2022 and is expected to showcase a significant CAGR in the forecast period. This is due to the increasing number of dental problems among children and adult population and increasing awareness for oral health.
APAC is expected to witness the highest CAGR of 5.7% during the forecast period owing to a favorable government initiative, large population, and availability of developed healthcare facilities in these countries. Dentists in densely populated nations like China and India frequently recommend dental implants to replace missing natural teeth, which are increasing in popularity. These nations also suffer from a significant load of dental and oral disorders, which is leading to increased demand for regular dental visits and checkups. In addition, China and India are currently the greatest producers and consumers of tobacco with the lowest awareness levels about smoking hazards. These are the elements that are anticipated to fuel the market for dental anesthesia in the area.
There are both small and major firms in the extremely competitive global market for dental anesthesia. In order to strengthen their market position and increase their market share, these organizations have implemented crucial business strategies like joint ventures, strategic alliances & collaborations, product innovation, new product launches, and contracts.
The rapid advancement of technology in the field of advanced dentistry is one of the main causes boosting competition among market participants. For instance, Septodont introduced the Dentapen electronic syringe for dental anesthetic in November 2018. Additionally, a lot of businesses are cooperating to create cutting-edge technologies in order to advertise their goods more quickly. The market leaders in Europe, such as DENTSPLY and Septodont, are helping to meet the rising demand for higher-quality healthcare and products, which will further fuel the expansion of the dental anesthesia market. Some prominent players in the dental anesthesia market include
Dentsply Sirona
Laboratorios Inibsa
Pierre Pharma
Septodont
Laboratorios Normon
Primex Pharmaceuticals
Aspen Group
Dentalhitec
Zeyco
Report Attribute |
Details |
Market size value in 2023 |
USD 1.97 billion |
Revenue forecast in 2030 |
USD 2.81 billion |
Growth rate |
CAGR of 5.2% from 2023 to 2030 |
Base year for estimation |
2022 |
Historic data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
Segments covered |
Type, end-use, region |
Regional scope
|
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Denstply Sirona; Laboratorios Inibsa; Pierre Pharma; Septodont; Laboratorios Normon; Primex Pharmaceuticals; Aspen Group; Dentalhitec; Zeyco |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global dental anesthesia market report based on type, end-use, and region:
Type Outlook, (Revenue, USD Million, 2018 - 2030)
Local
General
Sedation
End-use type Outlook, (Revenue, USD Million, 2018 - 2030)
Hospitals
Dental Clinics
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
India
Japan
China
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global dental anesthesia market size was estimated at USD 1,879.8 million in 2022 and is expected to reach USD 1,969.7 million in 2023.
b. The global dental anesthesia market is expected to grow at a compound annual growth rate of 5.2% from 2023 to 2030 to reach USD 2.81 billion by 2030.
b. Asia Pacific dominated the dental anesthesia market with a share of 38.6% in 2022. It is anticipated to grow substantially owing to the rising dental disorders and growing oral health awareness in this region.
b. Some key players operating in the dental anesthesia include Denstply Sirona, Laboratorios Inibsa, Pierre Pharma, Septodont, Laboratorios Normon, Primex Pharmaceuticals, Aspen Group, Dentalhitech, Zeyco, and others.
b. The rising demand for dental checkups and the increased prevalence of dental problems are two factors that are primarily driving the growth of the dental anesthesia market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."